U.S. drugmaker Merck is nearing a deal worth about $10 billion to buy Verona Pharma, a company focused on therapies for lung ...

Merck will buy UK-based Verona Pharma for about $10 billion, the companies said on Wednesday, strengthening the U.S. firm's ...

Merck said it will buy Verona Pharma for $10 billion to bolster its lung-disease business and help replace the expected loss ...

Company’s New Groundbreaking Preclinical Data in NSCLC Models Provides Further Validation for SIL204's Innovative Delivery ...

Lung cancer, the second-most common cancer in the U.S., is often associated with smoking — but even those who have never had ...

The primary measure of ILD progression was a decline in forced vital capacity (FVC) of 5% or more between annual visits.

Corticosteroids are commonly prescribed to alleviate cancer-related symptoms in patients with non-small cell lung cancer, ...

DURING SCREENING SEASON, which runs from March to December, LUCAS sets off on Mondays from the cancer institute in Morgantown ...

A fundamental discovery by University of Missouri scientists could help solve one of the most frustrating challenges in ...

Exposure to a common fungal molecule can reprogram immune cells in the lungs, causing them to overreact to infection-like ...

An international study found that air pollution leads to more cancer-related genetic changes than secondhand smoke.

Australia has launched its first lung cancer screening program, which targets current and recent smokers with biennial ...